Found: 31
Select item for more details and to access through your institution.
Safety and risk of febrile recurrence after early antibiotic discontinuation in high-risk neutropenic patients with haematological malignancies: a multicentre observational study.
- Published in:
- 2022
- By:
- Publication type:
- journal article
SARS-CoV-2 T-Cell Responses in Allogeneic Hematopoietic Stem Cell Recipients following Two Doses of BNT162b2 mRNA Vaccine.
- Published in:
- Vaccines, 2022, v. 10, n. 3, p. 448, doi. 10.3390/vaccines10030448
- By:
- Publication type:
- Article
Interest of a third dose of BNT162b2 anti‐SARS‐CoV‐2 messenger RNA vaccine after allotransplant.
- Published in:
- British Journal of Haematology, 2022, v. 196, n. 5, p. e38, doi. 10.1111/bjh.17911
- By:
- Publication type:
- Article
Safety and antibody response after one and/or two doses of BNT162b2 Anti‐SARS‐CoV‐2 mRNA vaccine in patients treated by CAR T cells therapy.
- Published in:
- British Journal of Haematology, 2022, v. 196, n. 2, p. 360, doi. 10.1111/bjh.17818
- By:
- Publication type:
- Article
Azacitidine in patients older than 80 years with acute myeloid leukaemia or myelodysplastic syndromes: a report on 115 patients.
- Published in:
- British Journal of Haematology, 2020, v. 190, n. 3, p. 461, doi. 10.1111/bjh.16680
- By:
- Publication type:
- Article
A novel complete blood count‐based score to screen for myelodysplastic syndrome in cytopenic patients.
- Published in:
- British Journal of Haematology, 2018, v. 183, n. 5, p. 736, doi. 10.1111/bjh.15626
- By:
- Publication type:
- Article
Phase I study of zoledronic acid combined with escalated doses of interleukine‐2 for early in vivo generation of Vγ9Vδ2 T‐cells after haploidentical stem cell transplant with posttransplant cyclophosphamide.
- Published in:
- American Journal of Hematology, 2024, v. 99, n. 3, p. 350, doi. 10.1002/ajh.27191
- By:
- Publication type:
- Article
Long-Lasting HHV-6 Reactivation in Long-Term Adult Survivors After Double Umbilical Cord Blood Allogeneic Stem Cell Transplantation.
- Published in:
- Journal of Infectious Diseases, 2014, v. 210, n. 4, p. 567, doi. 10.1093/infdis/jiu129
- By:
- Publication type:
- Article
Sequential allogeneic hematopoietic stem cell transplantation for active refractory/relapsed myeloid malignancies: results of a reduced-intensity conditioning preceded by clofarabine and cytosine arabinoside, a retrospective study on behalf of the SFGM-TC.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Progression of disease within 2 years (POD24) is a clinically relevant endpoint to identify high-risk follicular lymphoma patients in real life.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Absence of influence of peripheral blood CD34+ and CD3+ graft cell counts on outcomes after reduced-intensity conditioning transplantation using post-transplant cyclophosphamide.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Pomalidomide, cyclophosphamide, and dexamethasone for relapsed/refractory multiple myeloma patients in a real-life setting: a single-center retrospective study.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Successful treatment of congenital erythropoietic porphyria using matched unrelated hematopoietic stem cell transplantation in an adult: A case report.
- Published in:
- Skin Health & Disease, 2024, v. 4, n. 2, p. 1, doi. 10.1002/ski2.342
- By:
- Publication type:
- Article
Late Relapse after Allogeneic Stem Cell Transplantation in Patients Treated for Acute Myeloid Leukemia: Relapse Incidence, Characteristics, Role of Conditioning Regimen, and Outcome.
- Published in:
- Cancers, 2024, v. 16, n. 7, p. 1419, doi. 10.3390/cancers16071419
- By:
- Publication type:
- Article
Assessment of COVID-19 Incidence and Severity Among Recipients of Allogenic Stem Cell Transplant After 1 or 2 mRNA Booster Doses During the Omicron Wave in France.
- Published in:
- JAMA Network Open, 2022, v. 5, n. 12, p. e2247534, doi. 10.1001/jamanetworkopen.2022.47534
- By:
- Publication type:
- Article
Impact of allogeneic stem cell transplantation comorbidity indexes after haplotransplant using post‐transplant cyclophosphamide.
- Published in:
- Cancer Medicine, 2021, v. 10, n. 20, p. 7194, doi. 10.1002/cam4.4262
- By:
- Publication type:
- Article
A new cytokine‐based dynamic stratification during induction is highly predictive of survivals in acute myeloid leukemia.
- Published in:
- Cancer Medicine, 2021, v. 10, n. 2, p. 642, doi. 10.1002/cam4.3648
- By:
- Publication type:
- Article
Post‐transplant cyclophosphamide as sole GHVD prophylaxis after matched reduced‐intensity conditioning allotransplant.
- Published in:
- Clinical & Translational Medicine, 2023, v. 13, n. 4, p. 1, doi. 10.1002/ctm2.1242
- By:
- Publication type:
- Article
Peripheral levels of monocytic myeloid‐derived suppressive cells before and after first induction predict relapse and survivals in AML patients.
- Published in:
- Journal of Cellular & Molecular Medicine, 2022, v. 26, n. 21, p. 5486, doi. 10.1111/jcmm.17576
- By:
- Publication type:
- Article
Nocardia Infections in Hematopoietic Cell Transplant Recipients: A Multicenter International Retrospective Study of the Infectious Diseases Working Party of the European Society for Blood and Marrow Transplantation.
- Published in:
- Clinical Infectious Diseases, 2022, v. 75, n. 1, p. 88, doi. 10.1093/cid/ciab866
- By:
- Publication type:
- Article
Antithymocyte globulin administration in patients with profound lymphopenia receiving a PBSC purine analog/busulfan-based conditioning regimen allograft.
- Published in:
- Scientific Reports, 2020, v. 10, n. 1, p. N.PAG, doi. 10.1038/s41598-020-72415-7
- By:
- Publication type:
- Article
Effectiveness of a third dose of BNT162b2 anti‐SARS‐CoV‐2 mRNA vaccine over a 6‐month follow‐up period in allogenic hematopoietic stem cells recipients.
- Published in:
- Hematological Oncology, 2022, v. 40, n. 5, p. 1097, doi. 10.1002/hon.3006
- By:
- Publication type:
- Article
Safety and Antibody Response After 1 and 2 Doses of BNT162b2 mRNA Vaccine in Recipients of Allogeneic Hematopoietic Stem Cell Transplant.
- Published in:
- JAMA Network Open, 2021, v. 4, n. 9, p. e2126344, doi. 10.1001/jamanetworkopen.2021.26344
- By:
- Publication type:
- Article
Strong SARS-CoV-2 T-Cell Responses after One or Two COVID-19 Vaccine Boosters in Allogeneic Hematopoietic Stem Cell Recipients.
- Published in:
- Cells (2073-4409), 2022, v. 11, n. 19, p. 3010, doi. 10.3390/cells11193010
- By:
- Publication type:
- Article
Grade 2 acute GVHD is a factor of good prognosis in patients receiving peripheral blood stem cells haplo-transplant with post-transplant cyclophosphamide.
- Published in:
- Acta Oncologica, 2021, v. 60, n. 4, p. 466, doi. 10.1080/0284186X.2020.1837947
- By:
- Publication type:
- Article
Dramatic Recovery after Etoposide Phosphate Infusion for Hemophagocytic Lymphohistiocytosis/Macrophage Activation Syndrome following Treatment with Tisagenlecleucel in a Young Patient with Relapsed Acute Lymphoblastic Leukemia: A Case Report.
- Published in:
- Acta Haematologica, 2022, v. 145, n. 5, p. 537, doi. 10.1159/000525576
- By:
- Publication type:
- Article
Pre-exposure prophylaxis with tixagevimab/cilgavimab (AZD7442) prevents severe SARS-CoV-2 infection in recipients of allogeneic hematopoietic stem cell transplantation during the Omicron wave: a multicentric retrospective study of SFGM-TC.
- Published in:
- Journal of Hematology & Oncology, 2022, v. 15, n. 1, p. 1, doi. 10.1186/s13045-022-01387-0
- By:
- Publication type:
- Article
Assessment of monocytic‐myeloid‐derived suppressive cells (M‐MDSC) before and after allogeneic hematopoietic stem cell transplantation in acute leukemia patients.
- Published in:
- EJHaem, 2023, v. 4, n. 4, p. 1089, doi. 10.1002/jha2.795
- By:
- Publication type:
- Article
Efficacy of anti‐severe acute respiratory syndrome coronavirus 2 mRNA vaccines in adults with severe acquired aplastic anemia with or without allogeneic hematopoietic stem cell transplantation.
- Published in:
- EJHaem, 2022, v. 3, n. 4, p. 1442, doi. 10.1002/jha2.570
- By:
- Publication type:
- Article
Anti‐SARS‐CoV‐2 vaccines in recipient and/or donor before allotransplant.
- Published in:
- EJHaem, 2022, v. 3, n. 2, p. 484, doi. 10.1002/jha2.398
- By:
- Publication type:
- Article
Safety and immunogenicity of a first dose of SARS‐CoV‐2 mRNA vaccine in allogeneic hematopoietic stem‐cells recipients.
- Published in:
- EJHaem, 2021, v. 2, n. 3, p. 520, doi. 10.1002/jha2.242
- By:
- Publication type:
- Article